AI Voice Analysis Spots Hidden Concussions at a Client's First Intake Call

NeuroLexIQ and Canary Speech launch the first objective tool to catch brain injuries early — when it matters most for personal injury clients

What it does: Analyzes speech patterns during a structured intake call to flag potential concussion
When it's used: At first client contact — before any doctor's exam
What the output is: The CPR flags potential injury; paired qEEG testing collects and preserves FDA-cleared neurodiagnostic data — making the full report litigation-ready
How to access: Contact NeuroLexIQ to join the May 1 pilot — see details below

Knoxville, TN — April 21, 2026

Every year, thousands of people walk away from car crashes and falls with concussions that go unseen for weeks or months. Symptoms hide. Evidence fades. And clients lose the chance to prove what happened.

That changes today.

NeuroLexIQ, The Brain Injury Authority, has partnered with Canary Speech, a global leader in AI-powered voice biomarkers, to introduce the NeuroLexIQ–Canary CPR (Concussion Probability Report). This client-first platform analyzes subtle patterns in a person's voice during a structured intake conversation — identifying potential brain injury early enough to initiate qEEG validation and lock in the evidentiary chain before symptoms fade and causation becomes harder to prove.

A Breakthrough Built on Proven Technology

Canary Speech's AI has earned worldwide recognition for detecting cognitive and behavioral changes through everyday speech. Its technology analyzes natural speech patterns during a structured intake conversation, turning a simple client call into a clinical-grade evaluation — producing real data about an invisible injury at the precise moment a client first reaches out for help. For personal injury attorneys, early objective documentation has been shown to strengthen demand lettersand reduce time-to-settlement. The CPR makes that possible from day one.

“We are incredibly excited about this partnership. Capturing brain injury data quickly — then supporting it with objective EEG studies — lets us move forward with confidence.”
— Henry O’Connell, CEO, Canary Speech
“For the first time, attorneys have a tool that makes the invisible visible. This isn’t just better documentation — it’s a way to give clients their voice back, literally and figuratively. Looking ahead, we hope to deploy this as a real-time safety tool in contact sports — the arena where this work began more than six years ago.”
— Mark Slaughter, Founder & CEO, NeuroLexIQ

Validation Pilot Launches May 1

Starting May 1, NeuroLexIQ and Canary Speech will run a structured validation pilot. Client voice data from the CPR will be compared directly against qEEG brain mapping — a recognized neurodiagnostic standard of care. The pilot is designed to produce peer-reviewed validation data supporting admissibility under Daubert and Frye standards, delivering clear, defensible medical evidence that stands up in records, negotiations, and court.

Clients who move forward receive full access to qEEG testing, board-certified neurotrauma interpretation, medical record review, and causation analysis — every step grounded in objective science.

Personal injury firms interested in joining the pilot can contact NeuroLexIQ at
NeuroLexIQ Logo
About NeuroLexIQ
NeuroLexIQ is a brain injury identification and documentation company dedicated to helping individuals prove and present concussions with clear, objective evidence.
Canary Speech Logo
About Canary Speech
Canary Speech is a global leader in AI-powered voice biomarker technology, enabling early detection of neurological conditions through the analysis of everyday speech.